Giannini Sandro, Buda Roberto, Vannini Francesca, Di Caprio Francesco, Grigolo Brunella
University of Bologna, Rizzoli Orthopaedic Institute, Via G.C. Pupilli 1, 40136, Bologna, Italy.
Am J Sports Med. 2008 May;36(5):873-80. doi: 10.1177/0363546507312644. Epub 2008 Jan 28.
Autologous chondrocyte implantation (ACI) in the ankle was considered up to now an extremely technically demanding surgery with considerable morbidity for the patients.
Hyalograft C scaffold allows arthroscopic ACI, thanks to a specifically designed instrumentation.
Case series; Level of evidence, 4.
Forty-six patients with a mean age of 31.4 years (range, 20-47) underwent operation from 2001 to 2004. They had posttraumatic talar dome lesions, type II or IIA. In the first step of surgery, an ankle arthroscopy was performed, with cartilage harvest from the detached osteochondral fragment or from the margins of the lesion. Chondrocytes were cultured on a Hyalograft C scaffold. In the second step of surgery, the Hyalograft C patch was arthroscopically implanted into the lesion, with a specifically designed instrumentation. Lesions >5 mm deep were first filled with autologous cancellous bone. Patients were evaluated clinically with the American Orthopaedic Foot and Ankle Society (AOFAS) score preoperatively and at 12 and 36 months after surgery. At a mean time interval of 18 months, the first 3 patients underwent a second-look arthroscopy with cartilage harvest from the implant and histological examination.
The mean preoperative AOFAS score was 57.2 +/- 14.3. At the 12-month follow-up, the mean AOFAS score was 86.8 +/- 13.4 (P < .0005), while at 36 months after surgery, the mean score was 89.5 +/- 13.4 (P < .0005). Clinical results were significantly related to the age of patients and to previous operations for cartilage repair. The results of the histological examinations revealed hyaline-like cartilage regeneration.
The Hyalograft C scaffold and the specifically designed instrumentation allowed arthroscopic implantation of chondrocytes, with excellent clinical and histological results.
迄今为止,踝关节自体软骨细胞移植(ACI)被认为是一项技术要求极高的手术,给患者带来相当大的发病率。
由于采用了专门设计的器械,Hyalograft C支架可实现关节镜下ACI。
病例系列;证据等级,4级。
2001年至2004年,46例平均年龄31.4岁(范围20 - 47岁)的患者接受了手术。他们患有创伤后距骨穹窿病变,II型或IIA型。在手术的第一步,进行踝关节镜检查,从分离的骨软骨碎片或病变边缘获取软骨。软骨细胞在Hyalograft C支架上培养。在手术的第二步,使用专门设计的器械将Hyalograft C补片关节镜下植入病变部位。深度>5 mm的病变首先用自体松质骨填充。术前以及术后12个月和36个月,采用美国矫形足踝协会(AOFAS)评分对患者进行临床评估。平均间隔18个月时,前3例患者接受了二次关节镜检查,从植入物获取软骨并进行组织学检查。
术前AOFAS平均评分为57.2 ± 14.3。在12个月随访时,AOFAS平均评分为86.8 ± 13.4(P <.0005),而在术后36个月,平均评分为89.5 ± 13.4(P <.0005)。临床结果与患者年龄以及先前的软骨修复手术显著相关。组织学检查结果显示有透明软骨样再生。
Hyalograft C支架和专门设计的器械实现了软骨细胞的关节镜下植入,临床和组织学结果优异。